Sign inJoin waitlistJoin the waitlist

ND

Nikolay Delev

Credentials: · · · ·

History

Rheumatology
2010–2012
Internal Medicine
Advocate Health Care
2007–2010
Doctor of Medicine
1999–2003

Research

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
Arthritis & Rheumatology · 2023 · 209 citations
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus
New England Journal of Medicine · 2022 · Last of 17 authors · 79 citations
Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
Annals of the Rheumatic Diseases · 2018 · 65 citations

Victoria Werth
6 papers
JM
Joan Merrill
5 papers
Richard Furie
5 papers
Arthur Kavanaugh
3 papers
PM
Philip Mease
3 papers
CH
Coburn Hobar
2 papers
JA
Jacob Aelion
2 papers
MP
Marilyn Pike
2 papers
PL
Peter Lipsky
2 papers
SS
Shalabh Singhal
2 papers
SB
Subhashis Banerjee
2 papers
Aimee Payne
1 paper